Search

Search Constraints

You searched for: Author/Creator Tauchi, Tetsuzo

Search Results

1. BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma. Issue 5 (16th April 2019)

2. Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38–44]. (June 2019)

3. Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis. (4th March 2018)

4. Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis. Issue 7 (July 2015)

6. Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib. (April 2019)

7. Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib. Issue 9 (9th July 2013)

9. Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocations. (February 2018)